Hear from our Executive Committee on how Sanofi is doing more to make a positive impact on global health and environmental sustainability.
To establish more sustainable access, we will also build on our longstanding geographic and scientific footprint to work hand-in-hand with health authorities and care providers to improve the resilience of local health systems. The experience of the COVID-19 pandemic has shone a spotlight on the need to do more for those in need, and has brought us even closer to our purpose. At Sanofi, we know we can do more."
Olivier Charmeil, General Medicines
Building an Inclusive Workplace
"The COVID-19 pandemic has brought us many challenges, including the notion of “workplace.” We have seen that flexible working works and for us, that means reinventing the employee experience. But where we work is not the only issue that has come to the fore in the past year. We all watched the social pandemic of race spill onto the streets in worldwide protests to support Black Lives Matter. We have always worked to establish a diverse and inclusive workplace, but now is the moment to accelerate our efforts.
The business and societal advantages that come from a diverse and inclusive environment are significant, which is why this is an integral part of our social impact strategy. It will be integrated into the career development of our leaders and will be critical to attract and keep the best people at Sanofi. We also want to reflect this inclusive mindset outside the company in the communities we serve, ensuring diversity and inclusivity in clinical trials, in our selection criteria with our suppliers, and by involving local leadership teams in community projects. At Sanofi, we know we can do more."
Natalie Bickford, Chief People Officer
But we have also thought broadly about vulnerable communities and have recognized the huge gap in treatment for children who suffer from cancer. Our R&D teams include world-class scientists who have deep knowledge of the specific challenges of pediatric oncology, and understand the crucial need to find treatment. We seek to address the needs of the youngest cancer patients by identifying and developing promising molecules in our pre-clinical pipeline. At Sanofi, we know we can do more."
John Reed, Global Head of Research & Development
We are embedding our commitment to protect the planet into our broader social impact strategy with ambitious objectives and qualitative targets. These include an eco-friendly design for our new products by 2025, as well as renewable electricity on all our sites and a 100% carbon neutral sales car fleet, both by 2030. There is still a lot of work to be done, but our teams are ready to turn our ambitions into reality. At Sanofi, we know we can do more."
Julie Van Ongevalle, Consumer Healthcare